Asthma Management with Advair

Introduction to Asthma Treatment

The American College of Allergy, Asthma, and Immunology recommends initiating therapy with fluticasone 100 mcg/salmeterol 50 mcg twice daily (Advair 100/50) for adults with mild to moderate asthma, which corresponds to low-dose inhaled corticosteroid therapy 1
The Global Initiative for Asthma suggests that this dosing provides 200 mcg/day total fluticasone, falling within the low-dose ICS category of 88-264 mcg/day for adults 1
Most patients achieve satisfactory asthma control at this starting dose, according to the National Asthma Education and Prevention Program 1

For moderate to severe asthma, the American Thoracic Society recommends using fluticasone 250 mcg/salmeterol 50 mcg twice daily (Advair 250/50) for patients with moderate persistent asthma or those inadequately controlled on low-dose ICS 1, 2
This combination is more effective than fluticasone 500 mcg alone for moderate to severe asthma, as stated by the European Respiratory Society 1
The 250/50 strength provides medium-dose ICS therapy (500 mcg/day total fluticasone), according to the Journal of Allergy and Clinical Immunology 3

The National Institutes of Health recommends administering twice daily, approximately 12 hours apart, to maintain steady therapeutic levels 1, 2
Consistency in timing helps maintain steady therapeutic levels, as suggested by the American Academy of Allergy, Asthma, and Immunology 2
Show 1-3 months of stability before reducing the inhaled steroid dose, according to the National Asthma Education and Prevention Program 1
Decrease by 25-50% at each step when stepping down, as recommended by the Global Initiative for Asthma 1

The American College of Chest Physicians states that long-acting beta-agonists should never be used alone for asthma and must always be combined with inhaled corticosteroids 1, 2
Monotherapy with LABAs increases risk of severe exacerbations and asthma-related deaths, as reported by the European Respiratory Society 1, 2
The Journal of Allergy and Clinical Immunology notes that salmeterol-related side effects include tremor, tachycardia, hypokalemia, headache, and muscle cramps 3, 1
Fluticasone-related side effects include oral candidiasis, dysphonia, and cough, according to the American Thoracic Society 3, 1

The American Academy of Pediatrics recommends that Advair Diskus 100/50 is approved for children 4-11 years 1
Most children ≥4 years can generate sufficient inspiratory flow for the Diskus device, as stated by the National Institutes of Health 1
For children under 4 years, budesonide nebulizer suspension is the only FDA-approved ICS, according to the Journal of Allergy and Clinical Immunology 3
No dose adjustment is required based on age alone for elderly patients, as recommended by the American Geriatrics Society 1
Monitor closely for tremor from salmeterol and systemic corticosteroid effects in elderly patients, as suggested by the National Institutes of Health 1